Last reviewed · How we verify

Fiboran (APRINDINE)

FDA-approved active Small molecule Quality 24/100

At a glance

Generic nameAPRINDINE
Drug classaprindine
TargetCytochrome P450 2D6
ModalitySmall molecule
Therapeutic areaMetabolic
PhaseFDA-approved

Approved indications

Common side effects

No common side effects on file.

Competitive intelligence

For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape: